Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Vaccine Market: By Technology: Recombinant and Conjugate Vaccine, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Others; By Indication; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Vaccine Market Outlook

The global vaccine market attained a value of USD 57.55 billion in 2021. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 10.80% to reach USD 106.49 billion by 2027.

 

Global Vaccine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Heightened Demand for Booster Vaccines Fuelled by the Spread of SARS-CoV-2 to Augment the Vaccine Industry Growth

According to WHO, SARS-CoV-2 has impacted the health and immunity systems of people around the world and is expected to influence vaccine industry. Due to the rise in COVID-19 cases globally, there has been a sudden rise in demand for vaccines, which aided the market growth in the historical period. In this regard, the rapid development of COVID-19 vaccines and booster doses is projected to propel the industry growth in the coming years.

India, being one of the significant pharmaceutical manufacturing countries, is witnessing a growth in COVID-19 vaccine production. This can be attributed to the low manufacturing costs in the country compared to other nations. Additionally, the introduction of the Universal Immunisation Program (UIP) aimed at raising immunisation coverage against treatable diseases in the nation is projected to substantially increase the market growth in the forecast period. The market is further expected to be fuelled by the rapid technological advancements in the coming years.

 

Vaccine: Market Segmentation

Vaccine refers to a liquid injection or medication, which is a biological preparation that helps an individual’s system to recognise and eliminate harmful germs, bacteria, and viruses. Vaccines are administered as a preventive measure rather than a treatment. It helps train the immune system to generate antibodies, when the body is exposed to a disease.

 

Global Vaccine Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on technology, the market can be divided into:

  • Recombinant and Conjugate Vaccine
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Others

The market can be segmented, on the basis of indication, into:

  • Pneumococcal Disease
  • Influenza
  • Human Papilloma Virus
  • Meningococcal Disease
  • Rotavirus
  • Varicella, Measles, Mumps, and Rubella
  • Diptheria, Pertussis, and Tetanus (DPT)
  • Polio
  • Hepatitis
  • JE (Japanese Encephalitis) Vaccine
  • Others

The market can be broadly categorised on the basis of its end-use segments into:

  • Paediatric Vaccine
  • Adult Vaccine
  • Travellers Vaccine

The EMR report looks into the regional markets of vaccine like North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

 

Global Vaccine Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Heightened Expenditure in the Research and Development Activities to Propel the Market Growth

The increasing investments by the leading industry players in research and development activities for the production of effective vaccines and medications are projected to bolster the market growth in the forecast period. This trend can be attributed to the increasing awareness regarding the importance of vaccination worldwide. However, according to the WHO, the increased availability of new manufacturers, especially in Asia, is aiding in the expansion of the supplier base for pneumococcal conjugate vaccines, rotavirus vaccines, and regional  vaccines, which is leading to a more competitive market. Additionally, the rising incidences of chronic illnesses are projected to aid the market growth with the increased demand for preventive immunisation shots. Moreover, the growing geriatric population with heightened susceptibility to a number of disorders is also predicted to supplement the market growth in the coming years.

 

Key Industry Players in the Global Vaccine Market

The report presents a detailed analysis of the following key players in the global vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • AstraZeneca plc.
  • Johnson & Johnson Services, Inc.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Technology, Indication, End Use, Region
Breakup by Technology Recombinant and Conjugate Vaccine, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Others
Breakup by Indication Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease,
Rotavirus, Varicella, Measles, Mumps, and Rubella, Diptheria, Pertussis, and Tetanus (DPT), Polio, Hepatitis, JE (Japanese Encephalitis) Vaccine, Others
Breakup by End Use Paediatric Vaccine, Adult Vaccine, Travellers Vaccine
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, AstraZeneca plc., Johnson & Johnson Services, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Vaccine Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Vaccine Historical Market (2017-2021) 
    8.3    Global Vaccine Market Forecast (2022-2027)
    8.4    Global Vaccine Market by Technology
        8.4.1    Recombinant and Conjugate Vaccine
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Inactivated Vaccines
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Live Attenuated Vaccines
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Toxoid Vaccines
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    Others
    8.5    Global Vaccine Market by Indication
        8.5.1    Pneumococcal Disease
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Influenza
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Human Papilloma Virus
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Meningococcal Disease
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Rotavirus
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Varicella, Measles, Mumps, and Rubella
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2017-2021)
            8.5.6.3    Forecast Trend (2022-2027)
        8.5.7    Diptheria, Pertussis, and Tetanus (DPT)
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2017-2021)
            8.5.7.3    Forecast Trend (2022-2027)
        8.5.8    Polio
            8.5.8.1    Market Share
            8.5.8.2    Historical Trend (2017-2021)
            8.5.8.3    Forecast Trend (2022-2027)
        8.5.9    Hepatitis
            8.5.9.1    Market Share
            8.5.9.2    Historical Trend (2017-2021)
            8.5.9.3    Forecast Trend (2022-2027)
        8.5.10    JE (Japanese Encephalitis) Vaccine
            8.5.10.1    Market Share
            8.5.10.2    Historical Trend (2017-2021)
            8.5.10.3    Forecast Trend (2022-2027)
        8.5.11    Others
    8.6    Global Vaccine Market by End Use
        8.6.1    Paediatric Vaccine
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Adult Vaccine
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Travellers Vaccine
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global Vaccine Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    GlaxoSmithKline plc
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Novartis AG
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Pfizer Inc.    
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Sanofi    
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    AstraZeneca plc.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Johnson & Johnson Services, Inc.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Others
12    Industry Events and Developments


List of Key Figures and Tables

1.    Global Vaccine Market: Key Industry Highlights, 2017 and 2027
2.    Global Vaccine Historical Market: Breakup by Technology (USD Million), 2017-2021
3.    Global Vaccine Market Forecast: Breakup by Technology (USD Million), 2022-2027
4.    Global Vaccine Historical Market: Breakup by Indication (USD Million), 2017-2021
5.    Global Vaccine Market Forecast: Breakup by Indication (USD Million), 2022-2027
6.    Global Vaccine Historical Market: Breakup by End Use (USD Million), 2017-2021
7.    Global Vaccine Market Forecast: Breakup by End Use (USD Million), 2022-2027
8.    Global Vaccine Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Vaccine Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Vaccine Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Vaccine Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Vaccine Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Vaccine Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Vaccine Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Vaccine Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Vaccine Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Vaccine Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Vaccine Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Vaccine Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Vaccine Market Structure

Key Questions Answered in the Report

In 2021, the global vaccine market attained a value of nearly USD 57.55 billion.

The market is projected to grow at a CAGR of 10.80% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach USD 106.49 billion by 2027.

The major drivers of the industry, such as the insurgence of COVID-19 and its new variants, increasing health awareness among consumers, heightened investments in the pharmaceutical industry, and rapid technological advancements, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the rising incidences of chronic illnesses and the increasing investments in research and development activities.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The different technologies considered within the market report include recombinant and conjugate vaccine, inactivated vaccines, live attenuated vaccines, and toxoid vaccines, among others.

The significant market divisions, based on indication, include pneumococcal disease, influenza, human papilloma virus, meningococcal disease, rotavirus, varicella, measles, mumps, and rubella, diptheria, pertussis, and tetanus (DPT), polio, hepatitis, and JE (Japanese Encephalitis) vaccine, among others.

The major end uses of the product include paediatric vaccine, adult vaccine, and travellers vaccine.

The major players in the industry are GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, AstraZeneca plc., and Johnson & Johnson Services, Inc., among others.

Analyst Review

The global vaccine market attained a value of nearly USD 57.55 billion in 2021, driven by the rising prevalence of chronic illnesses worldwide. Aided by the growing investments in the pharmaceutical industry, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 10.80%. The market is projected to reach USD 106.49 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By technology, the market is segmented into recombinant and conjugate vaccine, inactivated vaccines, live attenuated vaccines, and toxoid vaccines, among others. Based on indication, the vaccine industry can be segmented into pneumococcal disease, influenza, human papilloma virus, meningococcal disease, rotavirus, varicella, measles, mumps, and rubella, diptheria, pertussis, and tetanus (DPT), polio, hepatitis, and JE (Japanese Encephalitis) vaccine, among others. The market can also be broadly categorised, on the basis of end use, into paediatric vaccine, adult vaccine, and travellers vaccine. The major regional markets for vaccine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, AstraZeneca plc., and Johnson & Johnson Services, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER